Phage-Derived Endolysins Targeting Cutibacterium acnes: A Scoping Review
Antibiotics · 17.07.2026 · 15 (7) · 697
DOI: 10.3390/antibiotics15070697 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Antibiotics, online erschienen am 17.07.2026. Verfasst von Magdalena Sołtys und 3 weiteren Autor:innen. Beteiligte Einrichtung: Students' Scientific Association of Cosmetology, Department of Cosmetology and Aesthetic Dermatology, Faculty of Pharmacy, Medical University of Lodz…. Die Arbeit nennt 72 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Acne vulgaris is a chronic inflammatory disorder of the pilosebaceous unit in which Cutibacterium acnes plays an important role in disease pathogenesis. Rising antimicrobial resistance has intensified interest in selective antimicrobial strategies for acne vulgaris. Bacteriophage-derived endolysins may offer targeted antibacterial activity while potentially sparing the skin microbiota. This scoping review aimed to map current evidence regarding endolysins targeting C. acnes and to evaluate their antibacterial activity, selectivity, safety, formulation challenges, and translational potential.
Methods
This scoping review was conducted in accordance with PRISMA-ScR guidelines. Searches on PubMed, Scopus, Embase, Web of Science, and Google Scholar were performed in February 2026. Experimental studies, academic theses, and patent documents investigating phage-derived endolysins active against C. acnes were included and narratively synthesised.
Results
Five peer-reviewed studies, three academic theses, and seven patent documents were included. Most available evidence originated from in vitro studies, with only one short-term clinical investigation identified. Endolysins and engineered derivatives demonstrated rapid bactericidal activity against C. acnes, including multidrug-resistant isolates, while several constructs exhibited minimal activity against selected commensal skin bacteria. Lysin-derived peptides retained activity under physiologically relevant pH and temperature conditions and in the presence of retinoic acid. Major translational challenges included limited stability of enzyme formulations, insufficient pilosebaceous unit penetration data, lack of anti-biofilm evidence and unstandardised microbiome assessment methods.
Conclusions
Phage-derived endolysins represent a promising targeted therapeutic strategy for acne vulgaris. However, current evidence remains predominantly preclinical, and substantial translational barriers related to delivery, stability, safety, anti-biofilm efficacy, microbiome homeostasis, and clinical validation must be addressed before routine dermatological application.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Students' Scientific Association of Cosmetology, Department of Cosmetology and Aesthetic Dermatology, Faculty of Pharmacy, Medical University of Lodz, Muszyńskiego 1, 91-151 Łódź, Poland.
- Students' Scientific Association of Clinical Microbiology, Department of Microbiology, Faculty of Medicine, Wroclaw Medical University, Chałubińskiego 4, 50-368 Wrocław, Poland.
- Department of Microbiology, Faculty of Medicine, Wroclaw Medical University, Chałubińskiego 4, 50-368 Wrocław, Poland.
- Department of Cosmetology and Aesthetic Dermatology, Faculty of Pharmacy, Medical University of Lodz, Muszyńskiego 1, 91-151 Łódź, Poland.
ORCID-Profile: Magdalena Sołtys, Rafał Kuczma, Katarzyna Jermakow, Anna Erkiert-Polguj
Zitieren
APA
Sołtys, M., Kuczma, R., Jermakow, K., & Erkiert-Polguj, A. (2026). Phage-Derived Endolysins Targeting Cutibacterium acnes: A Scoping Review. Antibiotics, 15(7), 697. https://doi.org/10.3390/antibiotics15070697
Vancouver
Sołtys M, Kuczma R, Jermakow K, Erkiert-Polguj A. Phage-Derived Endolysins Targeting Cutibacterium acnes: A Scoping Review. Antibiotics. 2026;15(7):697. doi:10.3390/antibiotics15070697
BibTeX
@article{Sotys2026,
author = {Sołtys, Magdalena and Kuczma, Rafał and Jermakow, Katarzyna and Erkiert-Polguj, Anna},
title = {Phage-Derived Endolysins Targeting Cutibacterium acnes: A Scoping Review},
journal = {Antibiotics},
year = {2026},
volume = {15},
number = {7},
pages = {697},
doi = {10.3390/antibiotics15070697}
}
EUVIMED